Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.11. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings | ||
DIH HOLDING US Aktie jetzt für 0€ handeln | |||||
15.11. | DIH HOLDING US, INC. - 10-Q/A, Quarterly Report | - | SEC Filings | ||
15.11. | DIH HOLDING US, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
15.11. | DIH Holding US GAAP EPS of -$0.01, revenue of $18.16M; initiates Q1 and updates FY25 outlook | 1 | Seeking Alpha | ||
14.11. | DIH Holding US, Inc.: DIH Announces Second Quarter 2025 Financial Results and Restates June 30, 2024 Form 10-Q | 69 | GlobeNewswire (Europe) | NORWELL, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual... ► Artikel lesen | |
14.11. | DIH HOLDING US, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
04.11. | DIH Holding appoints new COO to enhance operations | 1 | Investing.com | ||
04.11. | DIH Holding US, Inc.: DIH Appoints Dietmar Dold as Chief Operating Officer | 64 | GlobeNewswire (Europe) | NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human... ► Artikel lesen | |
04.11. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings | ||
10.10. | DIH HOLDING US, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
26.09. | DIH Holding US, Inc.: DIH Announces Formation and Inaugural Meeting of Scientific Advisory Board | 3 | GlobeNewswire (USA) | ||
26.09. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
17.09. | DIH HOLDING US, INC. - S-1/A, General form for registration of securities | 3 | SEC Filings | ||
06.09. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
30.08. | DIH Holding US, Inc.: DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence | 1 | GlobeNewswire (USA) | ||
30.08. | DIH HOLDING US, INC. - 8-K, Current Report | - | SEC Filings | ||
19.08. | DIH Holding US GAAP EPS of -$0.02, revenue of $16.19M | 1 | Seeking Alpha | ||
19.08. | DIH Holding US, Inc.: DIH Announces Fiscal 2025 First Quarter Financial Results | 132 | GlobeNewswire (Europe) | NORWELL, Mass., Aug. 19, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual... ► Artikel lesen | |
19.08. | DIH HOLDING US, INC. - 8-K, Current Report | 1 | SEC Filings | ||
19.08. | DIH HOLDING US, INC. - 10-Q, Quarterly Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 33,970 | -0,09 % | Neue 11,00% Multi Aktienanleihe auf Bayer, BioNTech und Fresenius in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Multi Aktienanleihe (ISIN DE000VC8M4R0/ WKN VC8M4R) mit Barriere (Worst-Of) Quanto auf... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 51,72 | -0,08 % | Siemens Healthineers Aktie: Ein positiver Ausblick! | ||
FRESENIUS MEDICAL CARE | 45,710 | +2,08 % | Fresenius Medical Care Aktie: Fortschritt kennt keine Grenzen | ||
GERRESHEIMER | 75,00 | -0,27 % | Gerresheimer: Neue Werkshalle in Skopje stärkt globale Kapazitäten für Glasspritzen | Die Gerresheimer AG, ein führender System- und Lösungsanbieter für die Pharma-, Biotech- und Kosmetikindustrie, investiert massiv in die Erweiterung ihrer Produktionskapazitäten. In Skopje, Nordmazedonien... ► Artikel lesen | |
CARL ZEISS MEDITEC | 58,70 | +2,09 % | Carl Zeiss Meditec-Aktie mit Kursverlusten (56,70 €) | Im Minus liegt zur Stunde der Anteilsschein von Carl Zeiss Meditec . Der jüngste Kurs betrug 56,70 Euro. An der Börse liegt die Carl Zeiss Meditec-Aktie aktuell im Minus. Das Papier verbilligte sich... ► Artikel lesen | |
TEMPUS AI | 53,12 | -8,37 % | Spotlight on Tempus AI: Analyzing the Surge in Options Activity | ||
NANO-X IMAGING | 6,230 | -0,80 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
ECKERT & ZIEGLER | 47,420 | +2,64 % | Buy or Goodbye?: Die Analystenstimmen des Tages: Easyjet, CTS Eventim, Patrizia, Eckert & Ziegler | © Foto: Emmanuele Contini - picture alliance/NurPhoto/Emmanuele ContiniRBC hebt das Kursziel für Easyjet an. Während JJPMorgan hebt das Kursziel für CTS Eventim anhebt. Das sind die wichtigsten Analysten-Calls... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 93,60 | -5,92 % | 5 Analysts Assess PROCEPT BioRobotics: What You Need To Know | ||
UNITEDHEALTH | 545,80 | -6,06 % | Schock in Manhatten: UnitedHealth-Chef Brian Thompson erschossen! | © Foto: Stefan Jeremiah - dpaBrian Thompson, CEO von UnitedHealthcare, wurde am Mittwochmorgen vor dem Hilton Hotel in Midtown Manhattan erschossen.Ein tragisches Ereignis erschüttert die Gesundheitsbranche:... ► Artikel lesen | |
PROGYNY | 15,015 | +0,91 % | Here's What Led to a Sharp Drop in Progyny's (PGNY) Share Price | ||
HIMS & HERS HEALTH | 29,810 | -7,59 % | Check Out What Whales Are Doing With HIMS | ||
GENEDX | 78,86 | -0,90 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
THERMO FISHER | 490,55 | -2,48 % | How Is Thermo Fisher Scientific's Stock Performance Compared to Other Medical Devices Stocks? | ||
ESSILORLUXOTTICA | 231,80 | +1,36 % | JPMORGAN stuft EssilorLuxottica auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat das Kursziel für EssilorLuxottica von 225 auf 255 Euro angehoben und die Einstufung auf "Overweight" belassen. Beim Optikkonzern setzt Analystin... ► Artikel lesen |